Articles published by ConcertAI

ConcertAI Introduces TeraRecon AV™, Advancing AI-Powered Medical Imaging with New Structural Heart and SaaS Capabilities

November 20, 2025

From ConcertAI

Via Business Wire

ConcertAI’s TeraRecon DETECT™ Helps Identify Opportunities to Optimize AI Imaging Reimbursement Workflows, Expanding Patient Access to the Most Advanced Care

November 20, 2025

From ConcertAI

Via Business Wire

ConcertAI Appoints Dr. Shaalan Beg as Chief Medical Officer, Oncology

October 21, 2025

From ConcertAI

Via Business Wire

ConcertAI’s TeraRecon Surpasses 2,000 Global Customers, Accelerating Cloud-First SaaS Transformation to Further Unlock Productivity for Healthcare Providers

September 25, 2025

From ConcertAI

Via Business Wire

Casey Graves Joins ConcertAI as General Manager, Clinical Solutions

September 11, 2025

From ConcertAI

Via Business Wire

CancerLinQ Receives ASCO Certified™ RQS Recognition Enabling Automated Quality Tracking That Helps Oncology Care Practices Save Critical Time and Resources

August 27, 2025

From ConcertAI

Via Business Wire

ConcertAI Appoints Michael Myshrall as Chief Financial Officer

August 18, 2025

From ConcertAI

Via Business Wire

ConcertAI Provides Intelligent Automation of ASCO® Guidelines into its Generative and Agentic AI Precision Suite™ and CancerLinQ® SmartLinQ™ Solutions

May 31, 2025

From ConcertAI

Via Business Wire

ConcertAI Launches New Generative and Agentic AI-Powered Precision Suite™ Accelerating Oncology Insights and Actions for Healthcare and Life Sciences

May 30, 2025

From ConcertAI

Via Business Wire

ConcertAI Announces Leadership Transition to Accelerate AI Innovation and Growth

May 01, 2025

From ConcertAI

Via Business Wire

ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology

April 22, 2025

From ConcertAI

Via Business Wire

ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology

April 22, 2025

From ConcertAI

Via Business Wire

EY US unveils Jeff Elton of ConcertAI as an Entrepreneur Of The Year® 2025 New England Award finalist

April 21, 2025

From ConcertAI

Via Business Wire

ConcertAI’s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers

March 29, 2025

From ConcertAI

Via Business Wire

Exigent Research, Leading National Community Research Network, Partners with AI Leader ConcertAI to Integrate CARAai™ Precision Trial Solutions

February 03, 2025

From ConcertAI

Via Business Wire

ConcertAI presents CARAai Multi-LLM and Agentic AI for Clinical Development and Insights at NVIDIA GTC 2025

March 18, 2025

From ConcertAI

Via Business Wire

ConcertAI Presents at 43rd Annual J.P. Morgan Healthcare Conference: 2024 Results and 2025-2028 AI Solutions Roadmap

January 13, 2025

From ConcertAI

Via Business Wire

At SCOPE 2025, ConcertAI Announces Major Advances in Trial Technologies for Research Sites and Sponsors

February 03, 2025

From ConcertAI

Via Business Wire

ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research

December 05, 2024

From ConcertAI

Via Business Wire

ConcertAI Announces Cloud-Based SaaS Transformation of TeraRecon Portfolio, Expanding its AI-Enhanced Clinical Capabilities in Medical Imaging

December 02, 2024

From ConcertAI

Via Business Wire

TeraRecon’s New Intuition Product Line Delivers AI Productivity and Industry-leading Cardiac MR Workflows, All Delivered Through a Robust Software-as-a-Service (SaaS) Platform

October 23, 2024

From ConcertAI

Via Business Wire

ConcertAI Appoints James Salitan as General Counsel

October 01, 2024

From ConcertAI

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.